MH

Mariam Hassan

Vp, Global Health Economics And Outcomes Research (heor) at Insmed

Mariam Hassan has extensive work experience in the field of Health Economics and Outcomes Research (HEOR). MARIAM is currently serving as the VP, Global Health Economics and Outcomes Research at Insmed Incorporated since 2022. Prior to that, they worked as the Executive Director and Head, Global Health Economics and Outcomes Research at Insmed Pharmaceuticals from 2019 to 2022.

Before joining Insmed, Mariam held a significant role as the Director, Global Health Economics and Outcomes Research Team Lead, Global Market Access and Values at Vertex Pharmaceuticals from 2014 to 2019. MARIAM also worked as the Director of Health Economics and Outcomes Research at Sunovion Pharmaceuticals Inc. from 2012 to 2014.

MARIAM'scareer started at AstraZeneca, where they held multiple positions, including Associate Director and Manager in Health Economics and Outcomes Research from 2005 to 2012.

Mariam's early experience includes research assistant roles at West Virginia University, where they worked on projects related to State Medicaid Health Economics and State Worker's Compensation Insurance System. MARIAM also served as a teaching assistant at the School of Pharmacy during their time at the university.

Additionally, Mariam gained internship experience at Health Benchmarks, Inc., where they worked on WellPoint Health Plan HEOR projects.

Overall, Mariam Hassan has a strong background in Health Economics and Outcomes Research, with progressive responsibilities and diverse experiences in the pharmaceutical industry.

Mariam Hassan's education history includes a degree in health economics and outcomes research from West Virginia University, where they obtained a Doctor of Philosophy (Ph.D.). Prior to that, they completed their Bachelor of Pharmacy (B.Pharm.) degree at the University of Mumbai.

Links

Previous companies

West Virginia University logo
Vertex Pharmaceuticals logo
AstraZeneca logo

Timeline

  • Vp, Global Health Economics And Outcomes Research (heor)

    January, 2022 - present

View in org chart